Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Michiels

Showing results (271-280 of 345) with videos related to

Pageof 35
Sort By:
Brain : a Journal of Neurology|August 1, 1996
The influence of stimulus location on the brain activation pattern in detection and orientation discrimination. A PET study of visual attentionR Vandenberghe, P Dupont, B De Bruyn, et al.
Seminars in Thrombosis and Hemostasis|September 16, 2006
Guidelines for the evaluation of intravenous desmopressin and von Willebrand factor/factor VIII concentrate in the treatment and prophylaxis of bleedings in von Willebrand disease types 1, 2, and 3Jan J Michiels, Alain Gadisseur, Marc van der Planken, et al.
The American Journal of Dermatopathology|February 1, 1996
Cutaneous pathology in primary erythermalgiaJ P Drenth, V Vuzevski, T Van Joost, et al.
Thrombosis and Haemostasis|September 4, 2008
PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2Huub H D M van Vliet, Mies C Kappers-Klunne, Frank W G Leebeek, et al.
Archives of Neurology|October 12, 2005
Autosomal dominant erythermalgia associated with a novel mutation in the voltage-gated sodium channel alpha subunit Nav1.7Jan J Michiels, Rene H M te Morsche, Jan B M J Jansen, et al.
Best Practice & Research. Clinical Haematology|November 1, 2001
Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and managementJ J Michiels, U Budde, M van der Planken, et al.
Seminars in Thrombosis and Hemostasis|January 5, 2001
Strategies for the safe and effective exclusion and diagnosis of deep vein thrombosis by the sequential use of clinical score, D-dimer testing, and compression ultrasonographyJ J Michiels, G Freyburger, F van der Graaf, et al.
Journal of Clinical Pathology|September 1, 1981
Presence of immune complex-like material in sera of patients with paraproteinaemiaF Klein, G J Lafeber, Y E Jongepier-Geerdes, et al.
Seminars in Thrombosis and Hemostasis|September 16, 2006
The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia veraJan J Michiels, Zwi Berneman, Wilfried Schroyens, et al.
Seminars in Thrombosis and Hemostasis|July 1, 2006
The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disordersJan J Michiels, Hendrik De Raeve, Zwi Berneman, et al.
Pageof 35

Showing results (271-280 of 345) with videos related to

Sort By:
Pageof 35
Brain : a Journal of Neurology|August 1, 1996
The influence of stimulus location on the brain activation pattern in detection and orientation discrimination. A PET study of visual attentionR Vandenberghe, P Dupont, B De Bruyn, et al.
Seminars in Thrombosis and Hemostasis|September 16, 2006
Guidelines for the evaluation of intravenous desmopressin and von Willebrand factor/factor VIII concentrate in the treatment and prophylaxis of bleedings in von Willebrand disease types 1, 2, and 3Jan J Michiels, Alain Gadisseur, Marc van der Planken, et al.
The American Journal of Dermatopathology|February 1, 1996
Cutaneous pathology in primary erythermalgiaJ P Drenth, V Vuzevski, T Van Joost, et al.
Thrombosis and Haemostasis|September 4, 2008
PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2Huub H D M van Vliet, Mies C Kappers-Klunne, Frank W G Leebeek, et al.
Archives of Neurology|October 12, 2005
Autosomal dominant erythermalgia associated with a novel mutation in the voltage-gated sodium channel alpha subunit Nav1.7Jan J Michiels, Rene H M te Morsche, Jan B M J Jansen, et al.
Best Practice & Research. Clinical Haematology|November 1, 2001
Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and managementJ J Michiels, U Budde, M van der Planken, et al.
Seminars in Thrombosis and Hemostasis|January 5, 2001
Strategies for the safe and effective exclusion and diagnosis of deep vein thrombosis by the sequential use of clinical score, D-dimer testing, and compression ultrasonographyJ J Michiels, G Freyburger, F van der Graaf, et al.
Journal of Clinical Pathology|September 1, 1981
Presence of immune complex-like material in sera of patients with paraproteinaemiaF Klein, G J Lafeber, Y E Jongepier-Geerdes, et al.
Seminars in Thrombosis and Hemostasis|September 16, 2006
The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia veraJan J Michiels, Zwi Berneman, Wilfried Schroyens, et al.
Seminars in Thrombosis and Hemostasis|July 1, 2006
The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disordersJan J Michiels, Hendrik De Raeve, Zwi Berneman, et al.
Pageof 35